CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Dec. 8, 2017 — Neogen Corporation (NASDAQ: NEOG) today announced that its Board of Directors has approved a four-for-three stock split. With the split, shareholders of record on Dec. 18, 2017, will receive one additional share of stock for each three shares held. The stock split... Read more
14 December 2017 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has signed an agreement with Macquarie Capital, the corporate advisory and principal investment arm of Macquarie Group, for them to acquire 50% of Spectris’ environmental monitoring business EMS Brüel & Kjær (‘EMS B&K’) for a total... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team. Ms. Hoyt will join as Senior Vice President and Chief People Officer (CPO), starting January 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies, reporting to the CEO. “After... Read more
CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Dec. 6, 2017 — Neogen Corporation (NASDAQ: NEOG) announced today that Ed Bradley has advised the company of his intentions to retire to pursue his personal interests. Bradley, vice president of Neogen’s Food Safety division, began his career with Neogen 23 years ago, and for the... Read more
MADISON, WI USA (November 30, 2017) Promega Corporation’s new Maxwell® RSC PureFood Pathogen Kit offers food safety labs an easy and consistent automated DNA purification method for PCR-based testing of food pathogens. The kit does not require enzymatic pre-treatment and, when used in combination with the Maxwell RSC Instrument, can effectively purify DNA from 1 to 16 food... Read more
PARIS–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris. The leading-edge customer training center will offer demonstrations, instruction, and education in the latest genomics technologies from Illumina for up to 1,000 scientists a year, providing direct links to Illumina’s global network of facilities and in-house... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Citi Global Healthcare Conference, New York, NY on December 7, 2017 at 11:45 am Eastern Time. The webcast can be accessed in the Investor Relations section of Illumina’s web site under... Read more
21. Nov, 2017 The new approval builds on approvals for the earlier generation Fossomatic™ FC that was the first instrument in the world approved by both Microval in Europe and NCIMS/ FDA in the USA. Microval is a European certification organization for the validation and approval of alternative methods for the microbiological analysis of food... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more
Technology originally developed for Department of Defense field applications REDMOND, Wash., Nov. 9, 2017 /PRNewswire/ — Photonic BioSystems (www.photonicbiosystems.com) announces that they are actively seeking commercialization partners (licensees) to bring their Rapid Microbial Detection and Sampling technologies to market. The technologies enable rapid sampling, detection and measurement of bacteria, cells, microorganisms and microbial contaminants – including E. coli,... Read more